Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrocElite is a biotechnology and nutraceutical company focused on the stabilization and delivery of sulforaphane, a potent phytochemical derived from broccoli. The company developed a proprietary process to stabilize sulforaphane in its active form without the need for the precursor glucoraphanin or the enzyme myrosinase, which are typically required in other supplements. Their product line is designed to activate the Nrf2 pathway, supporting the body's natural antioxidant response and anti-inflammatory processes. BrocElite serves both the direct-to-consumer market and healthcare professionals with clinical-grade formulations aimed at improving cellular health and immune function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrocElite.